Table:
begin	end	state
1	19	cytoplasmic
20	40	transmembrane
41	45	non-cytoplasmic
46	67	transmembrane
68	85	cytoplasmic
86	107	transmembrane
108	126	non-cytoplasmic
127	147	transmembrane
148	158	cytoplasmic
159	180	transmembrane
181	198	non-cytoplasmic
199	218	transmembrane
219	243	cytoplasmic
244	263	transmembrane
264	289	non-cytoplasmic
290	315	transmembrane
316	334	cytoplasmic
335	356	transmembrane
357	361	non-cytoplasmic
362	385	transmembrane
386	406	cytoplasmic
407	428	transmembrane
429	433	non-cytoplasmic
434	453	transmembrane
454	468	cytoplasmic

Input:
>PP_3727
MTDSVEKIQLTRALKSRHIFMLSLGGVIGTGLFMGSGVTINQGGPVGAILAYLVAGLLMY
LVMVCLGELSVQMPVSGSFQAHATKYIGPATGFMIGWVYWMSWATTVGLEFTAAGMLMTR
WFPEVPIWYWSALFVVVLFGLNALATRAFGEAEYWFSGIKVATILGFIVIGLLVIFGAIP
LSSGAPAPMLNNLVGESLFPHGLSAVFAVMMTVVYAFQGCEIMGVAAGETEHPEKSIPRA
VRNVVFRVLIFYVLAIAVLSAIVPHEQAGLMESPFVQVFDMVGIPYAADLMNFVILTAIL
SVGNSGLYASTRILWAMSKTGMAPKSLSPLSKRGVPLRALSITLCFALISLMTSFVAADT
LFMVLMAVSGMSGTVTWIVIALAQYRFRKAWLRDGGQLQDLKYKAPLYPLVPLLCITLCS
SLFVFLALDETQRPSLYWGFGFIALCYAAYFFVNRRRQGAFAPSTPGV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server